Changes of Cardiopulmonary Function After Thrombolysis in Patients With Pulmonary Embolism

Dynamic Changes of Circulatory and Respiratory Function After Thrombolysis in Patients With Acute Pulmonary Embolism

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04757129

Acronym

CCFATAPE

Enrollment

Registered

2021-02-17

Start date

2020-01-01

Completion date

2024-09-30

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Pulmonary Embolism

Keywords

acute pulmonary embolism, thrombolysis, Alteplase, cardiopulmonary function

Brief summary

The investigators expect to enroll about 80-100 acute pulmonary embolism patients treated with thrombolysis in two hospitals. Dynamic changes of cardiopulmonary function after thrombolysis are detected to evaluate which indicators can quickly reflect the effectiveness of thrombolysis.

Detailed description

About 80-100 acute pulmonary embolism(APE) patients treated with thrombolysis are enrolled in the First Affiliated Hospital with Nanjing Medical University and Nanjing Drum Town Hospital from January 1, 2020, to June 30, 2024. According to the 2019 ESC guideline, the standards for thrombolysis in APE patients are as follows: within 2 weeks of onset; high-risk pulmonary embolism; medium-high-risk pulmonary embolism with symptoms of aggravation. Investigators dynamically monitor cardiopulmonary function of participants after thrombolysis, including blood pressure, heart rate, respiratory rate, blood gas analysis, 2-dimensional echocardiography (left and right ventricular diameter, pulmonary artery pressure, interventricular septum) and laboratory tests (cTnT,pro-BNP).participants are divided into two groups: thrombolytic success group and thrombolytic failure group according the previously reported criterion which is evaluated 48h after thrombolysis. Cardiopulmonary characteristics are analyzed to seek accurate and rapid index to reflect success of thrombolysis.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Inclusion criteria

* medium-high risk or high risk pulmonary embolism and treated with thrombolysis

Exclusion criteria

* lack of radiologic evidence to diagnose APE * death within 48 hours after thrombolytic therapy * unable to partner treatment and leaving hospitals * missing other necessary data * pregnancy

Design outcomes

Primary

Measure	Time frame	Description
cardiopulmonary function changes	48 hours after thrombolysis	changes of PO2，SBP，HR, cardiac ultrasound index and vasoactive drug dosage

Countries

China

Contacts

Primary ContactBin He, Master

hbhbwywy34@sina.com13770789159

Outcome results